Disruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly.

TitleDisruptions in asymmetric centrosome inheritance and WDR62-Aurora kinase B interactions in primary microcephaly.
Publication TypeJournal Article
Year of Publication2017
AuthorsSgourdou, P, Mishra-Gorur, K, Saotome, I, Henagariu, O, Tuysuz, B, Campos, C, Ishigame, K, Giannikou, K, Quon, JL, Šestan, N, Çağlayan, AO, Günel, M, Louvi, A
JournalSci Rep
Volume7
Pagination43708
Date Published2017 03 08
ISSN2045-2322
KeywordsAnimals, Aurora Kinase B, Brain, Cell Cycle, Cell Differentiation, Cell Proliferation, Centrosome, Consanguinity, Disease Models, Animal, Epistasis, Genetic, Fluorescent Antibody Technique, Gene Expression, Humans, Inheritance Patterns, Male, Mice, Mice, Knockout, Microcephaly, Mutation, Nerve Tissue Proteins, Neural Stem Cells, Pedigree, Whole Genome Sequencing
Abstract

Recessive mutations in WD repeat domain 62 (WDR62) cause microcephaly and a wide spectrum of severe brain malformations. Disruption of the mouse ortholog results in microcephaly underlain by reduced proliferation of neocortical progenitors during late neurogenesis, abnormalities in asymmetric centrosome inheritance leading to neuronal migration delays, and altered neuronal differentiation. Spindle pole localization of WDR62 and mitotic progression are defective in patient-derived fibroblasts, which, similar to mouse neocortical progenitors, transiently arrest at prometaphase. Expression of WDR62 is closely correlated with components of the chromosome passenger complex (CPC), a key regulator of mitosis. Wild type WDR62, but not disease-associated mutant forms, interacts with the CPC core enzyme Aurora kinase B and staining of CPC components at centromeres is altered in patient-derived fibroblasts. Our findings demonstrate critical and diverse functions of WDR62 in neocortical development and provide insight into the mechanisms by which its disruption leads to a plethora of structural abnormalities.

DOI10.1038/srep43708
Alternate JournalSci Rep
PubMed ID28272472
PubMed Central IDPMC5341122
Grant ListUL1 TR001863 / TR / NCATS NIH HHS / United States
U54 HG006504 / HG / NHGRI NIH HHS / United States
R01 HD075822 / HD / NICHD NIH HHS / United States